Long-term administration of a drug that mimics the hunger-signaling hormone ghrelin protected Alzheimer’s disease-model mice from memory deterioration, despite a high-glycemic-index (GI) diet, according to research published in the journal Scientific Reports by University of Alabama at Birmingham investigator Inga Kadish, Ph.D., and colleagues.
Alzheimer's Disease Center
Lowering the rates of Alzheimer's in the Deep South.
Our research focuses on lowering the high rates of Alzheimer’s disease in the Deep South. Alzheimer’s is a serious problem across the country, and by studying how it affects people in our region, we can find ways to help everyone impacted by the disease. [...]
Research
We are training the next generation of clinicians and researchers
We are committed to educating those who are engaged in investigating Alzheimer’s disease and dementia research at the basic science, translational, or clinical level through mentored training, learning opportunities, and exposure to contemporary research methods.
Education
Our clinical team provides world-class expertise and state-of-the-art care
Providing care for neurological disorders for more than 26,000 patients annually. Patients have access to a comprehensive range of modern diagnostic services, including neuroimaging, electro diagnostic studies, neuropsychological evaluations, and neurogenetics studies.
Patient Care